Did you hear about this? This eastern equine encephalitis is no joke. Have you seen the fatality rate? It's shocking. This is far worse than Covid. Why have we no vaccines or cures!
I was looking through science journals and I found this--> a trial in 2022. Emergent BioSolutions::: Looks like they dabbled here and gave up. NIAID has executed a commercialization license for the advanced development of the WEVEE vaccine candidate to the life sciences company Emergent BioSolutions in Gaithersburg, Maryland. Funding for manufacturing of WEVEE clinical trial material and pre-clinical studies was funded in part by an Interagency Agreement between NIAID and the U.S. Department of Defense (DOD) Joint Program Executive Office Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND). Media Advisory Thursday, May 12, 2022 Vaccine for rare but deadly mosquito-borne viruses shows promise in clinical trial Watch EBS.
Yeah I do too. Hey did you see I said something nice about you. https://www.elitetrader.com/et/threads/mrna-for-lung-cancer.380925/page-3#post-6013067
What something nice... maybe I'll hit that link. Regarding PD. I was doing some TA on the name and would you agree that is a head and shoulders look here and where that gets interesting.. people often say that you have to have an inverse head and shoulders pattern to indicate upside.. I do not always agree with that. I think it can be a pattern of stability.. But May 30 Left shoulder.. June 28 head Aug 12 right shoulder Q: Do you think a H&S pattern can be Constructive in a non uptrend? I'm not sure, I think you have to have an overall uptrend of some magnitude > if you go way out PD looks sick: a $50-$20 bleed.
THE SHORT REPORT- HIMS Citi says Lilly Zepbound offering 'shot across the bow' for compounders » 08:44 HIMS, LLY Watch $14.70-$14.80 if HIMS slips below on the way to $10. HIMS Hims & Hers Health, Inc. $16.05-0.68 (-4.06%)4:00 PM 08/26/24 NYSE | $USD | Pre-Market: $15.17 -0.88 (-5.48%) 8:55 AM
Newest member to our Space portfolio. Redwire selected to provide advanced RF payloads to contractor » 07:31 RDW Aug 9->B. Riley upgraded Redwire to Buy from Neutral with an unchanged price target of $8. The analyst attributes the recent drop in the shares to valuation concerns as well as reaction to a string of open market sales by controlling owner AE Industrial Partners. However, Redwire “remains entrenched on a shortlist of winners” in the new space economy, fueled by a strong portfolio of proprietary products and services that are enabling the next generation of space exploration and habitation, the analyst tells investors in a research note. Buy->RDW Redwire Corporation@$7.00 $6.93 0.21(+3.13%)4:00 PM 08/26/24 NYSE |$USD |Pre-Market:$7.02+0.09(+1.30%)8:42 AM
I saw the forms yesterday, yeap! “CAVA Group (CAVA) shares dropped more than 7% in recent premarket trading on Tuesday after the company in a regulatory filing on Monday disclosed Artal International's divesture of 6 million CAVA shares worth around $732 million. Earlier in June, Artal International sold 3 million shares worth around $262 million. Price. $114. Moomoo